Biostar Pharmaceuticals (Biostar Pharmaceuticals) Change In Receivables : $13.94 Mil (TTM As of Sep. 2017)

View and export this data going back to 2008. Start your Free Trial

What is Biostar Pharmaceuticals Change In Receivables?

Biostar Pharmaceuticals's change in receivables for the quarter that ended in Sep. 2017 was $0.07 Mil. It means Biostar Pharmaceuticals's Accounts Receivable declined by $0.07 Mil from Jun. 2017 to Sep. 2017 .

Biostar Pharmaceuticals's change in receivables for the fiscal year that ended in Dec. 2016 was $8.67 Mil. It means Biostar Pharmaceuticals's Accounts Receivable declined by $8.67 Mil from Dec. 2015 to Dec. 2016 .

Biostar Pharmaceuticals's Accounts Receivable for the quarter that ended in Sep. 2017 was $0.00 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Biostar Pharmaceuticals's liquidation value for the three months ended in Sep. 2017 was $-4.83 Mil.

Biostar Pharmaceuticals Change In Receivables Historical Data

The historical data trend for Biostar Pharmaceuticals's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biostar Pharmaceuticals Change In Receivables Chart

Biostar Pharmaceuticals Annual Data

Trend

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Change In Receivables

Get a 7-Day Free Trial

6.63

4.21

-7.44

5.45

8.67

Biostar Pharmaceuticals Quarterly Data
	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17
Change In Receivables	Get a 7-Day Free Trial															0.11	7.07	1.24	5.57	0.07

Biostar Pharmaceuticals Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Sep. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $13.94 Mil.

Biostar Pharmaceuticals (OTCPK:BSPM) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Biostar Pharmaceuticals's Days Sales Outstanding for the quarter that ended in Sep. 2017 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0	/	0	*	91
=

2. In Ben Graham's calculation of liquidation value, Biostar Pharmaceuticals's accounts receivable are only considered to be worth 75% of book value:

Biostar Pharmaceuticals's liquidation value for the quarter that ended in Sep. 2017 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	0.365	-	5.279	+	0.75 * 0	+	0.5 * 0.171
=	-4.83

Biostar Pharmaceuticals Change In Receivables Related Terms

Thank you for viewing the detailed overview of Biostar Pharmaceuticals's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Biostar Pharmaceuticals (Biostar Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Biostar Pharmaceuticals Inc (OTCPK:BSPM) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 588 Shiji Xi Avenue, Shaanxi Province, Xianyang, CHN, 712046

Website

http://www.biostarpharmaceuticals.com

Biostar Pharmaceuticals Inc through its subsidiaries involves in the development, manufacturing, and marketing of pharmaceutical products for a variety of diseases and conditions in the People's Republic of China where it generates most of its revenues. The company's products include Xin Ao Xing Oleanolic Acid Capsule, an over-the-counter (OTC) medicine for chronic hepatitis B. The current product line of the company also includes several other OTC products and approximately 15 prescription-based pharmaceuticals. Its products are derived from medicinal herbs that are either grown at its own facility or purchased from the suppliers.

Biostar Pharmaceuticals (Biostar Pharmaceuticals) Headlines

From GuruFocus

Biostar Pharmaceuticals Announces Receipt of Additional Delisting Determination Letter from Nasdaq

By Marketwired Marketwired • 08-23-2018

Biostar Announces Receipt of Nasdaq Continued Listing Deficiency Notice

By PRNewswire PRNewswire • 04-23-2018